Update of the vascular model of AMD.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed, 4 syntheses or guidelines pooled it.

1. Statins for age-related macular degeneration.The Cochrane database of systematic reviews · 2016
   Pooled it
2. Statins for age-related macular degeneration.The Cochrane database of systematic reviews · 2015
   Pooled it
3. Statins for age-related macular degeneration.The Cochrane database of systematic reviews · 2012
   Pooled it
4. Statins for age-related macular degeneration.The Cochrane database of systematic reviews · 2009
   Pooled it
5. Can HMG Co-A reductase inhibitors ("statins") slow the progression of age-related macular degeneration? The age-related maculopathy statin study (ARMSS).Clinical interventions in aging · 2008
   Trial
6. Color Doppler Imaging, Endothelin-1, Corneal Biomechanics and Scleral Rigidity in Asymmetric Age-Related Macular Degeneration.Clinical ophthalmology (Auckland, N.Z.) · 2024
   Article
7. Classification Maps: A New Mathematical Tool Supporting the Diagnosis of Age-Related Macular Degeneration.Journal of personalized medicine · 2023
   Article
8. Choroidal Vascular Impairment in Intermediate Age-Related Macular Degeneration.Diagnostics (Basel, Switzerland) · 2022
   Article
9. A histological study of atherosclerotic characteristics in age-related macular degeneration.Heliyon · 2022
   Article
10. Statins and the progression of age-related macular degeneration in the United States.PloS one · 2021
    Article
11. REvisiting Lipids in REtinal Diseases: A Focused Review on Age-related Macular Degeneration and Diabetic Retinopathy.Journal of lipid and atherosclerosis · 2020
    Review
12. Soy Protein Nanofiber Scaffolds for Uniform Maturation of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium.Tissue engineering. Part C, Methods · 2020
    Article
13. Ocular cytomegalovirus latency exacerbates the development of choroidal neovascularization.The Journal of pathology · 2020
    Article
14. Imatinib Sets Pericyte Mosaic in the Retina.International journal of molecular sciences · 2020
    Article
15. Immunization Against Oxidized Elastin Exacerbates Structural and Functional Damage in Mouse Model of Smoke-Induced Ocular Injury.Investigative ophthalmology & visual science · 2020
    Article
16. Choriocapillaris dropout in early age-related macular degeneration.Experimental eye research · 2020
    Article
17. 'Statins in retinal disease'.Eye (London, England) · 2018
    Review
18. A Revised Hemodynamic Theory of Age-Related Macular Degeneration.Trends in molecular medicine · 2016
    Review
19. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.Eye and vision (London, England) · 2016
    Review
20. Vasodilators, blood pressure-lowering medications, and age-related macular degeneration: the Beaver Dam Eye Study.Ophthalmology · 2014
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as